Roschier represents KKR and RWK BidCo in their SEK 11.6 billion public offer for Biotage

Recent work|April 25, 2025

RWK Bidco AB (RWK BidCo), indirectly wholly owned by KKR Funds, has announced a public cash offer to the shareholders of Biotage AB. The offer values Biotage at approximately SEK 11.6 billion. The board of directors of Biotage recommends that Biotage’s shareholders accept the offer. Roschier represents KKR and RWK BidCo in connection with the transaction.

Biotage is a global supplier and solutions partner to a wide range of customers within Drug Discovery and Development and Analytical Testing. With expertise in separation and purification technology and leveraging intelligent workflow solutions, the group aims to be the best partner advancing health solutions. The shares in Biotage are listed on Nasdaq Stockholm, Large Cap.

For more information about KKR, please visit KKR’s website at www.kkr.com.

Roschier’s core advisory team comprises Jens Bengtsson, Ola Sandersson, Mira Lewis, Pontus Berganäs, Evelina Pettersson, Sazan Anwar, and Edvin Eriksson.                                 

The advisory team also comprises Leo Lee, Carl Byström, Anton Örnberg, Alexander Paulson, Gustaf Zakrisson, Kristian Hugmark, Johan Wahlbom, Giada Maglione, Moa Engstam, Björn Johansson Heigis, Elias Olsson, Felicia Torstensson, Veronica Stiller, Elias Tuomainen, Elias Schildt, Elin Osbeck, Sofia Andersson, and Hanna Elveros.